CHICAGO -- Edoxaban (Savaysa) appeared at least on par with warfarin for 12-week thromboembolic prophylaxis after bioprosthetic valve surgical implant in a Japanese trial with a population largely ...

"Currently, we can use only vitamin K antagonists such as warfarin for patients early after bioprosthetic valve surgery," said lead study author Chisato Izumi, M.D., Ph.D., of the National ...

AHA 2024 Anticoagulant Considered After Bioprosthetic Valve Surgery Edoxaban was at least as effective as warfarin in preventing thromboembolism after bioprosthetic valve replacement in the ENBALV ...

Unlike warfarin, the standard treatment ... alternative to consider for patients who have received a bioprosthetic heart valve replacement," Izumi said in a meeting news release.

All the cusps of the bioprosthesis appeared ... follow-up visit after 3 months the valve appeared normal. We told the patient that we recommended long-term anticoagulation with apixaban.